A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation
NCT ID: NCT03382613
Last Updated: 2019-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
2000 participants
OBSERVATIONAL
2017-12-29
2019-12-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quality Improvement (QI) Program
Hospitals assigned to the QI program arm will begin the 4-month Preparatory Phase which is designed to introduce the institutional baseline reporting tools and materials related to performance improvement, and gain insight into their gaps in treatment, followed by 15 month Implementation Phase, which will consist of education, process, and engagement activities that are targeted at the hospital and healthcare provider level and then the Measurement Period at which time hospitals will complete a final survey to document specific interventions that were successfully implemented and perform a final retrospective chart review on selected patients.
No interventions assigned to this group
Usual Care
Hospitals assigned to the Usual Care arm will not participate in the structured QI program but will continue with their standard hospital practice in treating patients with atrial fibrillation (AF) at risk for ischemic stroke. Hospitals will also complete a final survey and final retrospective chart reviews during the Measurement Period.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary or secondary discharge International Classification of Diseases (ICD)-9/10 diagnosis code for AF paroxysmal (I48.0), persistent (I48.1), chronic (I48.2), or unspecified (427.31, I48.91)
* Proxied Congestive Heart failure (CHA2DS2-VASC) score greater than or equal to (\>=) 2 using ICD-9 diagnosis scoring algorithm developed previously. The scoring algorithm will be expanded to include ICD-10 codes
* Discharged to home, skilled nursing facility, inpatient rehabilitation, or nursing home
Exclusion Criteria
* Surgical procedure during hospitalization for open heart surgery, brain, or spine
* Intravenous heparin given on the day of discharge without warfarin/oral anticoagulant (OAC), antiplatelets, and/or aspirin
* History of left atrial appendage occlusion, including the Watchman device
* Any in-hospital (current hospitalization) bleeding identified by ICD-9/10 diagnosis codes
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Janssen Scientific Affairs, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janssen Scientific Affairs, LLC Clinical Trial
Role: STUDY_DIRECTOR
Janssen Scientific Affairs, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Banner Thunderbird
Glendale, Arizona, United States
Banner Desert Medical Center
Mesa, Arizona, United States
Banner Baywood Medical Center
Mesa, Arizona, United States
Banner Heart Hospital
Mesa, Arizona, United States
Banner University Medical Center
Phoenix, Arizona, United States
Banner Estrella
Phoenix, Arizona, United States
Banner Boswell Medical Center
Sun City, Arizona, United States
Banner Del Webb
Sun City West, Arizona, United States
Banner University Medical Center - South (BUMC-S)
Tucson, Arizona, United States
Banner University Medical Center - Tucson (BUMC-T)
Tucson, Arizona, United States
Banner North Colorado Medical Center
Greeley, Colorado, United States
Hartford Hospital
Hartford, Connecticut, United States
The Hospital of Central Connecticut
New Britain, Connecticut, United States
AMITA Adventist Medical Center Bolingbrook
Bolingbrook, Illinois, United States
AMITA Alexian Brothers Medical Center
Elk Grove Village, Illinois, United States
AMITA Adventist Medical Center Hinsdale
Hinsdale, Illinois, United States
AMITA St. Alexius Medical Center
Hoffman Estates, Illinois, United States
AMITA Adventist Medical Center La Grange
La Grange, Illinois, United States
SSM Health Good Samaritan Hospital
Mount Vernon, Illinois, United States
Ephraim McDowell Regional Medical Center
Danville, Kentucky, United States
St. Agnes Hospital
Baltimore, Maryland, United States
Borgess Medical Center
Kalamazoo, Michigan, United States
Fremont Health Medical Center
Fremont, Nebraska, United States
Penn Medicine - Princeton Health
Plainsboro, New Jersey, United States
AtlantiCare
Pomona, New Jersey, United States
Southside Hospital
Bay Shore, New York, United States
Our Lady of Lourdes Hospital
Binghamton, New York, United States
Long Island Jewish Forest Hills
Forest Hills, New York, United States
Huntington Hospital
Huntington, New York, United States
North Shore University Hospital
Manhasset, New York, United States
Long Island Jewish Med Ctr
New Hyde Park, New York, United States
Lenox Hill Hospital
New York, New York, United States
Long Island Jewish Valley Stream
Valley Stream, New York, United States
Samaritan Medical Center
Watertown, New York, United States
The Jewish Hospital - Mercy
Cincinnati, Ohio, United States
Mercy Anderson Hospital
Cincinnati, Ohio, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Mercy St. Rita's Medical Center
Lima, Ohio, United States
Mercy Lorain Regional Medical Center
Lorain, Ohio, United States
Mercy St. Charles Hospital
Oregon, Ohio, United States
University Hospitals Regional Hospitals
Richmond Heights, Ohio, United States
Mercy Health St Vincent Medical Center
Toledo, Ohio, United States
Mercy St. Anne Hospital
Toledo, Ohio, United States
Oklahoma Health Science Center
Oklahoma City, Oklahoma, United States
Saint Francis Hospital
Tulsa, Oklahoma, United States
St. Luke's University Health Network
Allentown, Pennsylvania, United States
St.Luke's University Health Network - St.Luke's Cardiology Associates
Bethlehem, Pennsylvania, United States
Geisinger Medical Center
Danville, Pennsylvania, United States
Geisinger Medical Center
Scranton, Pennsylvania, United States
Geisinger Wyoming Valley
Wilkes-Barre, Pennsylvania, United States
AnMed Health
Anderson, South Carolina, United States
Avera McKennan Hospital
Sioux Falls, South Dakota, United States
Hendrick Medical Center
Abilene, Texas, United States
Methodist Dallas Medical Center
Dallas, Texas, United States
Methodist Charlton Medical Center
Dallas, Texas, United States
Methodist Mansfield Medical Center
Mansfield, Texas, United States
Methodist Richardson Medical Center
Richardson, Texas, United States
Inova Alexandria Hospital
Alexandria, Virginia, United States
Inova Health Care Services
Falls Church, Virginia, United States
Riverside Regional Medical Center
Newport News, Virginia, United States
St Marys Medical Center
Huntington, West Virginia, United States
Monongalia County General Hospital Company
Morgantown, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NOPRODAFL0001
Identifier Type: OTHER
Identifier Source: secondary_id
CR108407
Identifier Type: -
Identifier Source: org_study_id